The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alphal-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alpha
- 30 September 1999
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 38 (9), 1325-1333
- https://doi.org/10.1016/s0028-3908(99)00055-6
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Helenalin, an Anti-Inflammatory Sesquiterpene Lactone from Arnica, Selectively Inhibits Transcription Factor NF-κBBiological Chemistry, 1997
- Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cellsFEBS Letters, 1996
- Characterization of IκB KinasesPublished by Elsevier BV ,1996
- IL-1β and TNFα, but not IL-6, induce α1- antichymotrypsin expression in the human astrocytoma cell line U373 MGNeuroReport, 1995
- Cytokine-modulating activity of tepoxalin, a new potential antirheumaticInternational Journal of Immunopharmacology, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- IL-6-mediated events in Alzheimer's disease pathologyImmunology Today, 1991
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970